Thermo Fisher Scientific Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $509.3636
- Today's High:
- $515
- Open Price:
- $515
- 52W Low:
- $474.8967
- 52W High:
- $609.0504
- Prev. Close:
- $514.94
- Volume:
- 1562636
Company Statistics
- Market Cap.:
- $198.74 billion
- Book Value:
- 113.362
- Revenue TTM:
- $43.52 billion
- Operating Margin TTM:
- 16.62%
- Gross Profit TTM:
- $19.00 billion
- Profit Margin:
- 13.14%
- Return on Assets TTM:
- 4.9%
- Return on Equity TTM:
- 13.26%
Company Profile
Thermo Fisher Scientific Inc had its IPO on 1978-01-13 under the ticker symbol TMO.
The company operates in the Healthcare sector and Diagnostics & Research industry. Thermo Fisher Scientific Inc has a staff strength of 130,000 employees.
Stock update
Shares of Thermo Fisher Scientific Inc opened at $515 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $509.36 - $515, and closed at $510.99.
This is a -0.77% slip from the previous day's closing price.
A total volume of 1,562,636 shares were traded at the close of the day’s session.
In the last one week, shares of Thermo Fisher Scientific Inc have slipped by -8.3%.
Thermo Fisher Scientific Inc's Key Ratios
Thermo Fisher Scientific Inc has a market cap of $198.74 billion, indicating a price to book ratio of 5.1084 and a price to sales ratio of 4.9176.
In the last 12-months Thermo Fisher Scientific Inc’s revenue was $43.52 billion with a gross profit of $19.00 billion and an EBITDA of $10.63 billion. The EBITDA ratio measures Thermo Fisher Scientific Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Thermo Fisher Scientific Inc’s operating margin was 16.62% while its return on assets stood at 4.9% with a return of equity of 13.26%.
In Q2, Thermo Fisher Scientific Inc’s quarterly earnings growth was a negative -16.8% while revenue growth was a negative 2.6%.
Thermo Fisher Scientific Inc’s PE and PEG Ratio
- Forward PE
- 24.4499
- Trailing PE
- 35.2216
- PEG
- 4.2837
Its diluted EPS in the last 12-months stands at $14.62 per share while it has a forward price to earnings multiple of 24.4499 and a PEG multiple of 4.2837. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Thermo Fisher Scientific Inc’s profitability.
Thermo Fisher Scientific Inc stock is trading at a EV to sales ratio of 5.631 and a EV to EBITDA ratio of 21.1593. Its price to sales ratio in the trailing 12-months stood at 4.9176.
Thermo Fisher Scientific Inc stock pays annual dividends of $1.3 per share, indicating a yield of 0.27% and a payout ratio of 6.53%.
Balance sheet and cash flow metrics
- Total Assets
- $94.11 billion
- Total Liabilities
- $14.11 billion
- Operating Cash Flow
- $-3585000000.00
- Capital Expenditure
- $284 million
- Dividend Payout Ratio
- 6.53%
Thermo Fisher Scientific Inc ended 2024 with $94.11 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $94.11 billion while shareholder equity stood at $43.80 billion.
Thermo Fisher Scientific Inc ended 2024 with $2.84 billion in deferred long-term liabilities, $14.11 billion in other current liabilities, 441000000.00 in common stock, $44.29 billion in retained earnings and $43.27 billion in goodwill. Its cash balance stood at $3.13 billion and cash and short-term investments were $3.13 billion. The company’s total short-term debt was $4,814,000,000 while long-term debt stood at $29.19 billion.
Thermo Fisher Scientific Inc’s total current assets stands at $20.00 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $8.02 billion compared to accounts payable of $2.42 billion and inventory worth $5.66 billion.
In 2024, Thermo Fisher Scientific Inc's operating cash flow was $-3585000000.00 while its capital expenditure stood at $284 million.
Comparatively, Thermo Fisher Scientific Inc paid $0.07 in dividends in 2024.
Other key metrics
- Current Trading Price
- $510.99
- 52-Week High
- $609.0504
- 52-Week Low
- $474.8967
- Analyst Target Price
- $626.22
Thermo Fisher Scientific Inc stock is currently trading at $510.99 per share. It touched a 52-week high of $609.0504 and a 52-week low of $609.0504. Analysts tracking the stock have a 12-month average target price of $626.22.
Its 50-day moving average was $539.77 and 200-day moving average was $548.2 The short ratio stood at 1.56 indicating a short percent outstanding of 0%.
Around 19.1% of the company’s stock are held by insiders while 9179.8% are held by institutions.
Frequently Asked Questions About Thermo Fisher Scientific Inc
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.